London · Delayed Price · Currency is GBP · Price in GBX Faron Pharmaceuticals Oy Statistics
Total Valuation
AIM:FARN has a market cap or net worth of GBP 221.11 million. The enterprise value is 228.72 million.
| Market Cap | 221.11M |
| Enterprise Value | 228.72M |
Important Dates
The last earnings date was Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:FARN has 111.95 million shares outstanding. The number of shares has increased by 55.54% in one year.
| Current Share Class | 111.95M |
| Shares Outstanding | 111.95M |
| Shares Change (YoY) | +55.54% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 24.57% |
| Owned by Institutions (%) | 8.53% |
| Float | 77.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -15.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89
| Current Ratio | 1.89 |
| Quick Ratio | 1.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -46.68% |
| Return on Invested Capital (ROIC) | -119.01% |
| Return on Capital Employed (ROCE) | -230.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -829,013 |
| Employee Count | 25 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -35,145 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.83% in the last 52 weeks. The beta is 1.08, so AIM:FARN's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -11.83% |
| 50-Day Moving Average | 206.80 |
| 200-Day Moving Average | 197.46 |
| Relative Strength Index (RSI) | 41.69 |
| Average Volume (20 Days) | 16,102 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.54M |
| Pretax Income | -26.56M |
| Net Income | -26.53M |
| EBITDA | -16.37M |
| EBIT | -16.54M |
| Earnings Per Share (EPS) | -0.25 |
Balance Sheet
The company has 11.60 million in cash and 19.21 million in debt, giving a net cash position of -7.61 million or -0.07 per share.
| Cash & Cash Equivalents | 11.60M |
| Total Debt | 19.21M |
| Net Cash | -7.61M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | -13.93M |
| Book Value Per Share | -0.12 |
| Working Capital | 5.98M |
Cash Flow
| Operating Cash Flow | -21.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:FARN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.54% |
| Shareholder Yield | n/a |
| Earnings Yield | -12.00% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |